Condition: Cancer · Psychosocial Functioning · Treatment Side Effects · Sponsor: Hacettepe University
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
This description comes directly from the study's public registry record.
İzgi BAYRAKTAR, PhD (c)- Lecturer · +905342996472 · izgibayraktar@gmail.com
Aygin Ekincioglu, Prof.Dr. -Head of department · +90 532 355 07 46 · aygin@hacettepe.edu.tr
Always discuss trial participation with your own doctor first.
| Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy | Ankara, Altındağ, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07130981